[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 2001 | 0 | 0.38 | 0 | 0 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0.17 | |||||
| 2012 | 0 | 0.5 | 0 | 0 | 7 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | |||||
| 2014 | 0 | 0.53 | 0 | 0 | 8 | 21 | 14 | 0 | 7 | 7 | 0 | 0 | 0.22 | |||||
| 2015 | 0 | 0.52 | 0 | 0 | 1 | 22 | 0 | 0 | 8 | 15 | 0 | 0 | 0.22 | |||||
| 2016 | 0.22 | 0.5 | 0.1 | 0.13 | 98 | 120 | 90 | 12 | 12 | 9 | 2 | 16 | 2 | 11 | 91.7 | 10 | 0.1 | 0.2 |
| 2017 | 0.15 | 0.52 | 0.14 | 0.16 | 119 | 239 | 90 | 34 | 46 | 99 | 15 | 114 | 18 | 30 | 88.2 | 11 | 0.09 | 0.21 |
| 2018 | 0.14 | 0.53 | 0.16 | 0.14 | 134 | 373 | 89 | 60 | 106 | 217 | 30 | 226 | 31 | 52 | 86.7 | 22 | 0.16 | 0.22 |
| 2019 | 0.1 | 0.54 | 0.16 | 0.09 | 131 | 504 | 68 | 81 | 187 | 253 | 25 | 360 | 31 | 68 | 84 | 33 | 0.25 | 0.21 |
| 2020 | 0.12 | 0.64 | 0.13 | 0.1 | 130 | 634 | 47 | 80 | 267 | 265 | 31 | 483 | 49 | 51 | 63.8 | 10 | 0.08 | 0.3 |
| 2021 | 0.08 | 0.74 | 0.1 | 0.07 | 124 | 758 | 39 | 79 | 346 | 261 | 22 | 612 | 45 | 49 | 62 | 10 | 0.08 | 0.27 |
| 2022 | 0.09 | 0.73 | 0.11 | 0.07 | 117 | 875 | 24 | 94 | 440 | 254 | 22 | 638 | 43 | 50 | 53.2 | 4 | 0.03 | 0.22 |
| 2023 | 0.07 | 0.69 | 0.06 | 0.05 | 111 | 986 | 21 | 61 | 501 | 241 | 18 | 636 | 32 | 34 | 55.7 | 6 | 0.05 | 0.2 |
| 2024 | 0.06 | 0.81 | 0.04 | 0.04 | 111 | 1097 | 10 | 46 | 547 | 228 | 13 | 613 | 25 | 31 | 67.4 | 3 | 0.03 | 0.23 |
| 2025 | 0.07 | 0.04 | 0.03 | 113 | 1210 | 0 | 53 | 600 | 222 | 15 | 593 | 19 | 39 | 73.6 | 1 | 0.01 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2017 | Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Herr, Timothy M ; Jonnalagadda, Siddhartha R ; Carson, Matthew B ; Berendsen, Mark A ; Starren, Justin ; Zeng, Zexian ; Luo, Yuan ; Thompson, William K. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6. Full description at Econpapers || Download paper | 10 |
| 2 | 2014 | Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Lependu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David ; Callahan, Alison ; Low, Yen ; Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave. In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790. Full description at Econpapers || Download paper | 9 |
| 3 | 2016 | Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Harmark, Linda ; Raine, June ; Leufkens, Hubert ; Kant, Agnes ; Sarinic, Viola Macolic ; Moretti, Ugo. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x. Full description at Econpapers || Download paper | 8 |
| 4 | 2019 | Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Liu, Weisong ; Yu, Hong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z. Full description at Econpapers || Download paper | 7 |
| 5 | 2018 | Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Star, Kristina ; Taavola, Henric ; Hunsel, Florence ; Grundmark, Birgitta ; Zekarias, Alem ; Watson, Sarah ; Chandler, Rebecca E ; Harmark, Linda. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2. Full description at Econpapers || Download paper | 7 |
| 6 | 2017 | Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Le, Hoa ; Rodriguez, Harold W ; Freifeld, Clark C ; Pierce, Carrie E ; Pamer, Carol ; Proestel, Scott ; Edwards, Ralph I ; Dasgupta, Nabarun ; Walderhaug, Mark ; Bouri, Khaled ; Brownstein, John S. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0. Full description at Econpapers || Download paper | 7 |
| 7 | 2017 | Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Edwards, Ralph I ; Caster, Ola ; Noren, Niklas G ; Juhlin, Kristina ; Fransson, Jonas ; Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3. Full description at Econpapers || Download paper | 6 |
| 8 | 2016 | Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Smith, Karen ; Oconnor, Karen ; Gonzalez, Graciela ; Malone, Dan ; Sarker, Abeed ; Ginn, Rachel ; Scotch, Matthew. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4. Full description at Econpapers || Download paper | 6 |
| 9 | 2016 | Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Cadogan, Cathal A ; Hughes, Carmel M. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5. Full description at Econpapers || Download paper | 6 |
| 10 | 2016 | Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authoritiesâ Views and Needs. (2016). Harmark, Linda ; Hunsel, Florence ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6. Full description at Econpapers || Download paper | 6 |
| 11 | 2016 | The Impact of Experiencing Adverse Drug Reactions on the Patientâs Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Rolfes, Lean ; Taxis, Katja ; Hunsel, Florence ; Puijenbroek, Eugene. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0. Full description at Econpapers || Download paper | 6 |
| 12 | 2016 | Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Hoekman, Jarno ; Ampadu, Haggar H ; Sartori, Daniele ; Olsson, Sten ; Pal, Shanthi N ; Bruin, Marieke L. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4. Full description at Econpapers || Download paper | 5 |
| 13 | 2019 | Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Duvall, Scott L ; Alba, Patrick R ; Patterson, Olga V ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y. Full description at Econpapers || Download paper | 5 |
| 14 | 2017 | Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Slattery, Jim ; Candore, Gianmario ; Genov, Georgy ; Houez, Francois ; Haerry, David ; Arlett, Peter ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1. Full description at Econpapers || Download paper | 5 |
| 15 | 2016 | Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. (2016). Angamo, Mulugeta Tarekegn ; Chalmers, Leanne ; Curtain, Colin M. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0444-7. Full description at Econpapers || Download paper | 5 |
| 16 | 2019 | Patient Registries: An Underused Resource for Medicines Evaluation. (2019). McGettigan, Patricia ; Castillon, Mireia ; Plueschke, Kelly ; Zondag, Daniel Nogueras ; Olmo, Carla Alonso ; Kurz, Xavier ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9. Full description at Econpapers || Download paper | 5 |
| 17 | 2019 | Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Kakar, Tabassum ; Wunnava, Susmitha ; Rundensteiner, Elke A ; Sen, Cansu ; Qin, Xiao. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9. Full description at Econpapers || Download paper | 5 |
| 18 | 2019 | Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Harmark, Linda ; Lewis, David J ; Newbould, Victoria ; Pierce, Carrie E ; Bodin-Parssinen, Stephanie ; Maskell, Simon ; Ptaszynska-Neophytou, Alicia ; Vries, Sieta T ; Gama, Sara ; Eemeren, Raphael ; Tregunno, Phil ; Dasgupta, Nabarun. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6. Full description at Econpapers || Download paper | 5 |
| 19 | 2017 | Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). , Peter ; Wong, Lisa ; Houez, Franois ; Ruiz, Carmen Lasheras ; Sutcliffe, Alastair ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x. Full description at Econpapers || Download paper | 5 |
| 20 | 2016 | The Patientâs Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9. Full description at Econpapers || Download paper | 4 |
| 21 | 2021 | Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. (2021). Mishalov, Ellen ; Savage, Elizabeth ; Leonard, Eileen ; Abatemarco, Danielle ; Patel, Bhavin ; Taylor, Robert ; Dobracki, Pawel ; Kjoersvik, Oeystein ; Cherry, Mark ; Huysentruyt, Kristof. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2. Full description at Econpapers || Download paper | 4 |
| 22 | 2024 | The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. (2024). Tuccori, Marco ; Manlik, Katrin ; Candore, Gianmario ; Mahaux, Olivia ; Brueckner, Andreas ; Sartori, Daniele ; Herdeiro, Maria Teresa ; Battini, Vera ; Salem, Myriam ; Hauben, Manfred ; Bate, Andrew ; Poluzzi, Elisabetta ; Goldman, Adam ; Alshammari, Thamir M ; Pariente, Antoine ; Faillie, Jean-Luc ; Begaud, Bernard ; Onakpoya, Igho J ; Drici, Milou-Daniel ; Khouri, Charles ; Salvo, Francesco ; Noseda, Roberta ; Dolladille, Charles ; Raschi, Emanuel ; Fusaroli, Michele ; Norn, Niklas G ; Cutroneo, Paola Maria ; Puijenbroek, Eugne ; Noguchi, Yoshihiro ; Crisafulli, Salvatore ; Hunsel, Florence ; Montastruc, Franois ; Carnovale, Carla. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:6:d:10.1007_s40264-024-01421-9. Full description at Econpapers || Download paper | 4 |
| 23 | 2018 | EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. (2018). Slattery, Jim ; Dogne, Jean-Michel ; Candore, Gianmario ; Domergue, Francois ; Haren, Anja ; Kurz, Xavier ; Brosch, Sabine ; Postigo, Rodrigo ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:7:d:10.1007_s40264-018-0647-1. Full description at Econpapers || Download paper | 4 |
| 24 | 2018 | From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Sultana, Janet ; Trifiro, Gianluca ; Bate, Andrew. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4. Full description at Econpapers || Download paper | 4 |
| 25 | 2016 | Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Rodriguez, Harold W ; Powell, Gregory E ; Reblin, Tjark ; Freifeld, Clark C ; Burstein, Phil J ; Pierce, Carrie E ; Dasgupta, Nabarun ; Menius, Alan J ; Thomas, Michele ; Brownstein, John S ; Painter, Jeffery L ; Blowers, James ; Bell, Heidi G ; Seifert, Harry A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6. Full description at Econpapers || Download paper | 4 |
| 26 | 2018 | Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Blin, Patrick ; Moore, Nicholas ; Duong, Mai ; Droz, Cecile ; Abouelfath, Abdelilah ; Lassalle, Regis. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7. Full description at Econpapers || Download paper | 4 |
| 27 | 2018 | Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. (2018). Pers, Yves-Marie ; Vernhet, Helene ; Roubille, Franois ; Chatre, Clotilde ; Jorgensen, Christian. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0689-4. Full description at Econpapers || Download paper | 4 |
| 28 | 2019 | Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Danysz, Karolina ; Mingle, Edward ; Abatemarco, Danielle ; Assuncao, Bruno ; Desai, Sameen ; Cicirello, Salvatore ; Mockute, Ruta ; Tetarenko, Niki. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z. Full description at Econpapers || Download paper | 4 |
| 29 | 2018 | Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Comfort, Shaun ; Nagarajan, Meenakshi ; Fine, Jennifer ; Dorrell, Darren ; Ramakrishnan, Cartic ; Hudson, Zoe ; Perera, Sujan ; Meireis, Shawman. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7. Full description at Econpapers || Download paper | 4 |
| 30 | 2017 | Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works. (2017). Arlett, Peter ; Raine, June ; Genov, Georgy ; Santoro, Aniello ; Spooner, Almath. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0572-8. Full description at Econpapers || Download paper | 4 |
| 31 | 2020 | Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Alqenae, Fatema A ; Steinke, Douglas. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3. Full description at Econpapers || Download paper | 4 |
| 32 | 2019 | MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Gong, Yan ; Yang, XI ; Hogan, William R ; Bian, Jiang. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0. Full description at Econpapers || Download paper | 4 |
| 33 | 2016 | Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Pratt, Nicole L ; Ellett, Lisa Kalisch ; Wahab, Izyan A ; Roughead, Elizabeth E. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8. Full description at Econpapers || Download paper | 4 |
| 34 | 2016 | A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Felix, Thomas ; Stergiopoulos, Stella ; Getz, Kenneth A ; Grampp, Gustavo ; Brown, Carrie A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4. Full description at Econpapers || Download paper | 4 |
| 35 | 2018 | What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects. (2018). al Ramimmy, Hussain ; Parthasarathi, Gurumurthy ; van Puijenbroek, Eugene ; Tanaka, Daisuke ; Koster, Andries S ; Schutte, Tim ; van Eekeren, Rike ; Harmark, Linda ; Rolfes, Lean ; Magro, Lara. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0681-z. Full description at Econpapers || Download paper | 4 |
| 36 | 2019 | Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. (2019). Roeleveld, Nel ; Puijenbroek, Eugene ; Winkel, Bernke ; Kant, Agnes ; Vorstenbosch, Saskia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0722-7. Full description at Econpapers || Download paper | 4 |
| 37 | 2024 | The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration. (2024). Bate, Andrew ; Hauben, Manfred ; Salem, Myriam ; Battini, Vera ; Herdeiro, Maria Teresa ; Sartori, Daniele ; Brueckner, Andreas ; Mahaux, Olivia ; Candore, Gianmario ; Manlik, Katrin ; Tuccori, Marco ; Carnovale, Carla ; Montastruc, Franois ; Hunsel, Florence ; Crisafulli, Salvatore ; Noguchi, Yoshihiro ; Puijenbroek, Eugne ; Cutroneo, Paola Maria ; Norn, Niklas G ; Fusaroli, Michele ; Raschi, Emanuel ; Dolladille, Charles ; Noseda, Roberta ; Salvo, Francesco ; Khouri, Charles ; Drici, Milou-Daniel ; Onakpoya, Igho J ; Begaud, Bernard ; Faillie, Jean-Luc ; Pariente, Antoine ; Alshammari, Thamir M ; Goldman, Adam ; Poluzzi, Elisabetta. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:6:d:10.1007_s40264-024-01423-7. Full description at Econpapers || Download paper | 4 |
| 38 | 2018 | Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Lerch, Magnus ; Dietrich, Juergen ; Stekelenborg, John ; Vroman, Benoit ; Wisniewski, Antoni ; Tcherny-Lessenot, Stephanie ; Maskell, Simon ; Caster, Ola ; Noren, Niklas G ; Kurzinger, Marie-Laure . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2. Full description at Econpapers || Download paper | 3 |
| 39 | 2017 | Pharmaceutical BenefitâRisk Communication Tools: A Review of the Literature. (2017). Lofstedt, Ragnar ; Blazsin, Hortense ; Bouder, Frederic ; Way, Dominic. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1. Full description at Econpapers || Download paper | 3 |
| 40 | 2019 | The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Corrao, Giovanni ; Clavenna, Antonio ; Gini, Rosa ; Trifiro, Gianluca ; Capuano, Annalisa ; Leone, Roberto ; Lapi, Francesco ; Cantarutti, Anna ; Leoni, Olivia ; Barone-Adesi, Francesco ; Vannacci, Alfredo ; Dellagiovanna, Mirosa ; Rea, Federico ; Mugelli, Alessandro ; Tettamanti, Mauro ; Beghi, Ettore ; Franchi, Matteo ; Lucenteforte, Ersilia ; Naldi, Luigi ; Poluzzi, Elisabetta ; Mantovani, Lorenzo ; Rafaniello, Concita ; Ingrasciotta, Ylenia ; Sultana, Janet ; Ferrajolo, Carmen ; Kirchmayer, Ursula ; Traversa, Giuseppe ; Carnovale, Carla ; Moretti, Ugo. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0732-5. Full description at Econpapers || Download paper | 3 |
| 41 | 2019 | Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Barmaz, Yves ; Menard, Timothe ; Bowling, Rich ; Popko, Leszek ; Koneswarakantha, Bjorn. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4. Full description at Econpapers || Download paper | 3 |
| 42 | 2021 | Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database. (2021). Fingar, Kathryn ; Wong, Hui Lee ; Munoz, Flor M ; Baer, Bethany ; Shoaibi, Azadeh ; Burrell, Timothy A ; Anderson, Steven ; Hobbi, Shayan ; Sheng, Minya ; Eckert, Linda O ; Moll, Keran. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:11:d:10.1007_s40264-021-01113-8. Full description at Econpapers || Download paper | 3 |
| 43 | 2019 | The Role of European Patient Organizations in Pharmacovigilance. (2019). Weits, Gerda ; Hunsel, Florence ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x. Full description at Econpapers || Download paper | 3 |
| 44 | 2017 | Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2. Full description at Econpapers || Download paper | 3 |
| 45 | 2017 | An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Singh, Sonal ; Marimuthu, Sathiya Priya ; Segal, Jodi B ; Iyer, Geetha. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1. Full description at Econpapers || Download paper | 3 |
| 46 | 2018 | Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs. (2018). Raine, June ; Janssen, Heidi ; Mazzaglia, Giampiero ; Alteri, Enrica ; Silva, Daniela ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0604-4. Full description at Econpapers || Download paper | 3 |
| 47 | 2020 | Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Menard, Timothe ; Bowling, Rich ; Popko, Leszek ; Rolo, Donato ; Koneswarakantha, Bjorn ; Barmaz, Yves. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3. Full description at Econpapers || Download paper | 3 |
| 48 | 2016 | National ADR Monitoring System in China. (2016). Hou, Yongfang ; Li, Xinling ; Ye, Xiaofei ; Wu, Guizhi. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5. Full description at Econpapers || Download paper | 3 |
| 49 | 2016 | Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Newbould, Victoria ; Goedecke, Thomas ; Brosch, Sabine ; Arlett, Peter ; Ord, Kathryn . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4. Full description at Econpapers || Download paper | 3 |
| 50 | 2019 | Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC). (2019). Mumford, Virginia ; Gates, Peter J ; Baysari, Melissa T ; Raban, Magdalena Z ; Westbrook, Johanna I. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:8:d:10.1007_s40264-019-00823-4. Full description at Econpapers || Download paper | 3 |
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2024 | The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration. (2024). Bate, Andrew ; Hauben, Manfred ; Salem, Myriam ; Battini, Vera ; Herdeiro, Maria Teresa ; Sartori, Daniele ; Brueckner, Andreas ; Mahaux, Olivia ; Candore, Gianmario ; Manlik, Katrin ; Tuccori, Marco ; Carnovale, Carla ; Montastruc, Franois ; Hunsel, Florence ; Crisafulli, Salvatore ; Noguchi, Yoshihiro ; Puijenbroek, Eugne ; Cutroneo, Paola Maria ; Norn, Niklas G ; Fusaroli, Michele ; Raschi, Emanuel ; Dolladille, Charles ; Noseda, Roberta ; Salvo, Francesco ; Khouri, Charles ; Drici, Milou-Daniel ; Onakpoya, Igho J ; Begaud, Bernard ; Faillie, Jean-Luc ; Pariente, Antoine ; Alshammari, Thamir M ; Goldman, Adam ; Poluzzi, Elisabetta. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:6:d:10.1007_s40264-024-01423-7. Full description at Econpapers || Download paper | 4 |
| 2 | 2024 | The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. (2024). Tuccori, Marco ; Manlik, Katrin ; Candore, Gianmario ; Mahaux, Olivia ; Brueckner, Andreas ; Sartori, Daniele ; Herdeiro, Maria Teresa ; Battini, Vera ; Salem, Myriam ; Hauben, Manfred ; Bate, Andrew ; Poluzzi, Elisabetta ; Goldman, Adam ; Alshammari, Thamir M ; Pariente, Antoine ; Faillie, Jean-Luc ; Begaud, Bernard ; Onakpoya, Igho J ; Drici, Milou-Daniel ; Khouri, Charles ; Salvo, Francesco ; Noseda, Roberta ; Dolladille, Charles ; Raschi, Emanuel ; Fusaroli, Michele ; Norn, Niklas G ; Cutroneo, Paola Maria ; Puijenbroek, Eugne ; Noguchi, Yoshihiro ; Crisafulli, Salvatore ; Hunsel, Florence ; Montastruc, Franois ; Carnovale, Carla. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:6:d:10.1007_s40264-024-01421-9. Full description at Econpapers || Download paper | 4 |
| 3 | 2017 | Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Herr, Timothy M ; Jonnalagadda, Siddhartha R ; Carson, Matthew B ; Berendsen, Mark A ; Starren, Justin ; Zeng, Zexian ; Luo, Yuan ; Thompson, William K. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6. Full description at Econpapers || Download paper | 3 |
| 4 | 2019 | Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Liu, Weisong ; Yu, Hong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z. Full description at Econpapers || Download paper | 3 |
| 5 | 2022 | âArtificial Intelligenceâ for Pharmacovigilance: Ready for Prime Time?. (2022). Ball, Robert ; Pan, Gerald Dal. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01157-4. Full description at Econpapers || Download paper | 2 |
| 6 | 2021 | Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. (2021). Mishalov, Ellen ; Savage, Elizabeth ; Leonard, Eileen ; Abatemarco, Danielle ; Patel, Bhavin ; Taylor, Robert ; Dobracki, Pawel ; Kjoersvik, Oeystein ; Cherry, Mark ; Huysentruyt, Kristof. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2. Full description at Econpapers || Download paper | 2 |
| 7 | 2018 | EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. (2018). Slattery, Jim ; Dogne, Jean-Michel ; Candore, Gianmario ; Domergue, Francois ; Haren, Anja ; Kurz, Xavier ; Brosch, Sabine ; Postigo, Rodrigo ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:7:d:10.1007_s40264-018-0647-1. Full description at Econpapers || Download paper | 2 |
| 8 | 2023 | Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review. (2023). Coughlin, Kevin ; Maro, Judith C ; Smith, Joshua C ; Hernandez-Muoz, Jose J ; Stojanovic, Danijela ; Wang, Shirley V ; Davis, Sharon E ; Desai, Rishi J ; Shah, Nigam H ; Zabotka, Luke. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01325-0. Full description at Econpapers || Download paper | 2 |
| 9 | 2023 | Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. (2023). Njotto, Lembris L ; Engstrand, Lars ; Simin, Johanna ; Mussche, Isabelle ; Odsbu, Ingvild ; Callens, Steven ; Fornes, Romina ; Bruyndonckx, Robin ; Brusselaers, Nele. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01297-1. Full description at Econpapers || Download paper | 2 |
| 10 | 2017 | Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works. (2017). Arlett, Peter ; Raine, June ; Genov, Georgy ; Santoro, Aniello ; Spooner, Almath. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0572-8. Full description at Econpapers || Download paper | 2 |
| 11 | 2024 | The Role of Pharmacogenomics in Rare Diseases. (2024). Carleton, Bruce C ; Man, Alice. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:6:d:10.1007_s40264-024-01416-6. Full description at Econpapers || Download paper | 2 |
| 12 | 2023 | Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study. (2023). , Nhung ; Vidlin, Sara Hedfors ; Hiltunen, Saara ; Spasic, Dimitrije ; Asikainen, Suvi ; Garca, Maria Teresa ; Schuemie, Martijn ; Sartori, Daniele ; Duarte-Salles, Talita ; Savage, Ruth ; Ryan, Patrick ; Danilovic, Ana ; Reyes, Carlen ; Prieto-Alhambra, Daniel ; Dedman, Daniel ; Ramrez-Anguita, Juan Manuel ; Rijnbeek, Peter ; Chalabi, Etir ; Pistillo, Andrea ; Mitchell, Joseph ; Zekarias, Alem ; Catal, Mart ; Sandberg, Lovisa ; Miladinovic, Jelena ; Wilde, Marcel ; Norn, Niklas G ; Rudolph, Annette ; Mayer, Miguel A ; Vujovic, Ankica ; Brand, Judith S ; Lazarevic, Milan ; Veljkovic, Nevena ; Gauffin, Oskar ; Jdicke, Annika M. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:12:d:10.1007_s40264-023-01353-w. Full description at Econpapers || Download paper | 2 |
| 13 | 2023 | Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update. (2023). Herdeiro, Maria Teresa ; Taracido, Margarita ; Costa, Catarina ; Torre, Carla ; Figueiras, Adolfo ; Garcia-Abeijon, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:7:d:10.1007_s40264-023-01302-7. Full description at Econpapers || Download paper | 2 |
| Year | Title | |
|---|---|---|
| 2025 | Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review. (2025). Golder, SU ; Xu, Dongfang ; Oconnor, Karen ; Wang, Yunwen ; Batra, Mahak ; Hernandez, Graciela Gonzalez. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:4:d:10.1007_s40264-024-01505-6. Full description at Econpapers || Download paper | |
| 2025 | Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide. (2025). Tangchitkhachon, Kunwarang ; Menniti-Ippolito, Francesca ; Alghamdi, Waad ; Skalli, Souad ; Koppel, Sonja ; Ekhart, Corine ; Hunsel, Florence ; Woerdenbag, Herman J ; Mponda, John Samson. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:1:d:10.1007_s40264-024-01480-y. Full description at Econpapers || Download paper | |
| 2025 | Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs. (2025). Barnhart, Huiman ; Hoofnagle, Jay H ; Bjornsson, Einar S ; Chen, Vincent L ; Rockey, Don C. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:2:d:10.1007_s40264-024-01486-6. Full description at Econpapers || Download paper | |
| 2025 | Microbiota-indole-3-propionic acid-heart axis mediates the protection of leflunomide against αPD1-induced cardiotoxicity in mice. (2025). Zhao, Shu-Hong ; Huang, Dan ; Shen, Zhuo-Yu ; Ma, Zhen-Guo ; Tang, Qi-Zhu ; Wu, Pan ; Dan, Ling-Xuan. In: Nature Communications. RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58107-8. Full description at Econpapers || Download paper | |
| 2025 | Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative Blueprint. (2025). Saragoussi, Delphine ; Nguyen, Viviana ; Toyserkani, Gita A ; Hamilton, Alison ; Smith, Meredith Y ; Davis, Rachel ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:7:d:10.1007_s40264-025-01533-w. Full description at Econpapers || Download paper | |
| 2025 | Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver Diseases. (2025). Amirzadegan, Jasmine ; Hayashi, Paul H ; Almario, Eileen Navarro ; Avigan, Mark I ; Pei, Veronica Y ; Tesfaldet, Bereket. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-024-01511-8. Full description at Econpapers || Download paper | |
| 2025 | Artificial Intelligence in Pharmacovigilance: Leadership for Ethical AI Integration and Human-AI Collaboration in the Pharmaceutical Industry. (2025). Saha, Krishnendu ; Okmen, Nimet. In: CAFE Working Papers. RePEc:akf:cafewp:34. Full description at Econpapers || Download paper | |
| 2025 | Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases. (2025). Puijenbroek, Eugene ; Weibel, Daniel ; Verhamme, Katia ; Sturkenboom, Miriam ; Roque-Pereira, Leonardo ; Sisay, Malede Mequanent ; Ogar, Comfort K ; Durn, Carlos E. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:10:d:10.1007_s40264-025-01561-6. Full description at Econpapers || Download paper | |
| 2025 | Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation. (2025). Lacivita, Cynthia ; Rasmussen, Sonja A ; Maro, Judith C ; Thai, Thuy ; Sarayani, Amir ; Toyserkani, Gita A ; Eggers, Sara ; Smolinski, Nicole E ; Zhou, Esther H ; Wang, Yanning ; Diaby, Vakaramoko ; Winterstein, Almut G ; Lackey, Leila. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:2:d:10.1007_s40264-024-01488-4. Full description at Econpapers || Download paper | |
| 2025 | Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study. (2025). Roustit, Matthieu ; Khouri, Charles ; Cracowski, Jean-Luc ; Raschi, Emanuel ; Fusaroli, Michele ; Salvo, Francesco ; Revol, Bruno ; Bernardeau, Claire. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:6:d:10.1007_s40264-025-01524-x. Full description at Econpapers || Download paper | |
| 2025 | Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database. (2025). Demourgues, Maxime ; Mascolo, Annamaria ; Capuano, Annalisa ; Salvo, Francesco ; Napoli, Raffaella ; Richez, Christophe ; Scavone, Cristina ; Singier, Allison. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:8:d:10.1007_s40264-025-01535-8. Full description at Econpapers || Download paper | |
| 2025 | Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study. (2025). , Sabine ; Zomerdijk, Inge M ; Bruin, Marie L ; Gardarsdottir, Helga. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:9:d:10.1007_s40264-025-01550-9. Full description at Econpapers || Download paper | |
| 2025 | Timeliness of yellow fever specimen collection and transport in Ghana, 2018â2022. (2025). Ossom, Robert ; Gudjinu, Horlali ; Boateng, Gifty ; Laryea, Dennis Odai ; Asiedu-Bekoe, Franklin ; Schroeder, Lee ; Judson, Seth D ; Kenu, Ernest ; Dowdy, David W ; Danquah, Jerry Fosu. In: PLOS Global Public Health. RePEc:plo:pgph00:0005703. Full description at Econpapers || Download paper | |
| 2025 | Potential distribution of Aedes vittatus as an invasive species in North America. (2025). Barve, Narayani ; Argudo, Victoria ; Martins, Paula Isla ; Ruiz-Utrilla, Zenia P ; Nuez-Penichet, Claudia ; Ng, Eric ; Peterson, Townsend A ; Alkishe, Abdelghafar. In: PLOS ONE. RePEc:plo:pone00:0335534. Full description at Econpapers || Download paper | |
| 2025 | Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction. (2025). Rossi, Andrea ; Carnovale, Carla ; Casula, Manuela ; Spina, Edoardo ; Sessa, Maurizio ; Barbieri, Maria Antonietta ; Abate, Andrea ; Ferdinandy, Pter ; Balogh, Olivr M ; Gg, Bence ; Ptervri, Mtys ; Battini, Vera ; Cocco, Marianna. In: Drug Safety. RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-025-01515-y. Full description at Econpapers || Download paper |
| Year | Citing document | |
|---|---|---|
| 2024 | Authorsâ Response to Huang et al.âs Comment on âSerially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillanceâ. (2024). Suchard, Marc A ; Bu, Fan ; Arshad, Faaizah ; Hripcsak, George ; Ryan, Patrick B ; Schuemie, Martijn J. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:4:d:10.1007_s40264-024-01411-x. Full description at Econpapers || Download paper | |
| 2024 | Not Just Another Reporting Guideline? Hereâs Why READUS-PV is a Major Step Forward. (2024). Loke, Yoon K. In: Drug Safety. RePEc:spr:drugsa:v:47:y:2024:i:6:d:10.1007_s40264-024-01441-5. Full description at Econpapers || Download paper |
| Year | Citing document | |
|---|---|---|
| 2023 | Forecasting euro area inflation with machine-learning models. (2023). Paredes, Joan ; Lenza, Michele ; Moutachaker, Ines. In: Research Bulletin. RePEc:ecb:ecbrbu:2023:0112:. Full description at Econpapers || Download paper | |
| 2023 | Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France. (2023). Germay, Sibylle ; Singier, Allison ; Salvo, Francesco ; Pariente, Antoine. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:12:d:10.1007_s40264-023-01359-4. Full description at Econpapers || Download paper | |
| 2023 | Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities. (2023). Bauchau, Vincent ; Frise, Sarah ; Davis, Kourtney ; Wilkins, Jamie ; Jouquelet-Royer, Corinne. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:4:d:10.1007_s40264-023-01290-8. Full description at Econpapers || Download paper | |
| 2023 | Authorâs Reply to Kuss and Rathmannâs Comment on: âDrug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Dataâ. (2023). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01293-5. Full description at Econpapers || Download paper | |
| 2023 | Authorsâ Reply to Juergen O Kirchnerâs Comment on âIncidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Projectâ. (2023). , Miriam ; Weibel, Daniel ; Willame, Corinne. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01311-6. Full description at Econpapers || Download paper | |
| 2023 | Comment on: âDeliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting Systemâ. (2023). Tuccori, Marco ; Bonaso, Marco ; Convertino, Irma ; Valdiserra, Giulia ; Cappello, Emiliano ; Ferraro, Sara. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:9:d:10.1007_s40264-023-01330-3. Full description at Econpapers || Download paper |
| Year | Citing document | |
|---|---|---|
| 2022 | Conundrum of Clinical QTc Monitoring. (2022). Malik, Marek. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:10:d:10.1007_s40264-022-01229-5. Full description at Econpapers || Download paper | |
| 2022 | Authorsâ Response to Yoshihiro Noguchiâs Comment on: âA Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)â. (2022). Tan, Malinda S ; Villa-Zapata, Lorenzo ; Horn, John ; Malone, Daniel C ; Gomez-Lumbreras, Ainhoa ; Boyce, Richard D. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01239-3. Full description at Econpapers || Download paper | |
| 2022 | Comment on: A Disproportionality Analysis of DrugâDrug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS). (2022). Noguchi, Yoshihiro. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01240-w. Full description at Econpapers || Download paper | |
| 2022 | Authorsâ Reply to Noguchiâs comment on: âDrug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.â. (2022). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:7:d:10.1007_s40264-022-01192-1. Full description at Econpapers || Download paper |